Publications by authors named "Allison Naleway"

Claim this Profile
E
Effectiveness of 2023-2024 COVID-19 Vaccines in Children in the United States.
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, Kristin Dascomb, Allison L Naleway

Pediatrics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.
Stephanie A Irving, Elizabeth A K Rowley, Sean Chickery, Karthik Natarajan, Nicola P Klein, Allison L Naleway

MMWR Morb Mortal Wkly Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women.
Allison Avrich Ciesla, Victoria Lazariu, Janet A Watts, Gabriela Vazquez-Benitez, Kristin Dascomb, Allison L Naleway

Obstet Gynecol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024.
Katherine Adams, Shikha Garg, Sara Y Tartof, Stephanie A Irving, Malini B DeSilva, Allison L Naleway

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016-2017 to 2019-2020: A Retrospective Cohort Study.
Aaron M Frutos, Mark W Tenforde, Devi Sundaresan, Allison L Naleway, Stephanie A Irving

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasons.
Stephanie A Irving, Holly C Groom, Edward A Belongia, Bradley Crane, Matthew F Daley, Allison L Naleway

Vaccine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental intent to vaccinate children with the updated 2023-2024 COVID-19 vaccine.
Holly C Groom, Jennifer L Kuntz, Alexandra M Varga, Ning Smith, Evelin Coto, Allison L Naleway

Vaccine· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study.
Collrane Frivold, Sarah N Cox, Lea Starita, Tara M Babu, Katherine L Hoffman, Allison L Naleway

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysis.
Amanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, Melissa S Stockwell, Sara Y Tartof, Allison L Naleway

Lancet Reg Health Am· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel.
Margarita Mishina, Weiping Cao, Zachary Ende, Suresh S Sharma, Sean D Ray, Allison L Naleway

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age.
Emily L Reeves, Kristin Dascomb, Stephanie A Irving, Nicola P Klein, Sara Y Tartof, Allison L Naleway

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024.
Stephanie A Irving, Bradley Crane, Eric S Weintraub, Suchita A Patel, Hilda Razzaghi, Allison L Naleway

Pediatrics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infections.
Grace E Quirk, Marta V Schoenle, Kameron L Peyton, Jennifer L Uhrlaub, Branden Lau, Allison Naleway

Nat Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Zoster Vaccination and Risk of Postherpetic Neuralgia or Zoster Ophthalmicus.
Ousseny Zerbo, Joan Bartlett, Bruce Fireman, Kristin Goddard, Jonathan Duffy, Allison L Naleway

JAMA Netw Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults.
Ruth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, Nicola P Klein, Shaun J Grannis, Allison L Naleway

JAMA Netw Open· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States.
Leora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, Craig B Borkowf, Jade James-Gist, Allison L Naleway

J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort - Oregon and Washington, 2022-2024.
Mila Shakya, Helen Y Chu, Janet A Englund, Melissa Briggs-Hagen, Marco Carone, Allison L Naleway

MMWR Morb Mortal Wkly Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023.
Sarah N Cox, Pavitra Roychoudhury, Collrane Frivold, Zack Acker, Tara M Babu, Allison L Naleway

Clin Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022.
Allison L Naleway, Bradley Crane, Stephanie A Irving, Matthew F Daley, Brian Dixon

Pediatr Infect Dis J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy.
Jennifer L Kuntz, Tara M Babu, Leora R Feldstein, Janet A Englund, Collrane J Frivold, Allison L Naleway

Pediatr Infect Dis J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years.
Anna R Yousaf, Josephine Mak, Lisa Gwynn, Karen Lutrick, Robin F Bloodworth, Allison Naleway

JAMA Netw Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.
Ruth Link-Gelles, Sean Chickery, Alexander Webber, Toan C Ong, Elizabeth A K Rowley, Allison L Naleway

MMWR Morb Mortal Wkly Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023.
Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, Lauren Grant, Tara M Babu, Allison L Naleway

J Pediatric Infect Dis Soc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods to Adjust for Confounding in Test-Negative Design COVID-19 Effectiveness Studies: Simulation Study.
Elizabeth Ak Rowley, Patrick K Mitchell, Duck-Hye Yang, Ned Lewis, Brian E Dixon, Allison L Naleway

JMIR Form Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.
James Hollister, Cynthia Porter, Ryan Sprissler, Shawn C Beitel, James K Romine, Allison L Naleway

PLoS One· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis